You are searching for: hsa04010

---

T97136 Target Info	Target Name	MAPK signal-integrating kinase 1 (MKNK1)
	Target type	Clinical trial Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	EFT508	Drug Info

T21307 Target Info	Target Name	MAPK-activated protein kinase 2 (MAPKAPK2)
	Target type	Clinical trial Target
	Disease	Hidradenitis suppurativa; Cryopyrin-associated periodic syndrome;
	Drugs	Zunsemetinib	Drug Info

T06031 Target Info	Target Name	MAPK/ERK kinase kinase 1 (MAP3K1)
	Target type	Clinical trial Target
	Disease	Not Available
	Drugs	CI-1040	Drug Info

T76508 Target Info	Target Name	MAPK/ERK kinase kinase 2 (MAP3K2)
	Target type	Clinical trial Target
	Disease	Not Available
	Drugs	CI-1040	Drug Info

T85670 Target Info	Target Name	Nerve growth factor (NGF)
	Target type	Clinical trial Target
	Disease	Chronic low back pain; Cancer related pain;
	Drugs	Tanezumab	Drug Info

T55260 Target Info	Target Name	Protein phosphatase 1A (PPM1A)
	Target type	Clinical trial Target
	Disease	Molluscum contagiosum infection; Common wart;
	Drugs	VP-102	Drug Info

T23673 Target Info	Target Name	Proto-oncogene c-RAF (c-RAF)
	Target type	Clinical trial Target
	Disease	Autoimmune diabetes; Inflammatory bowel disease;
	Drugs	Semapimod	Drug Info

T55398 Target Info	Target Name	Renal carcinoma antigen NY-REN-64 (IRAK-4)
	Target type	Clinical trial Target
	Disease	Atopic dermatitis; Rheumatoid arthritis;
	Drugs	GS-5718	Drug Info

T49989 Target Info	Target Name	TGF-beta receptor type II (TGFBR2)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	TGF-BR2 mab	Drug Info

T86552 Target Info	Target Name	Tumor necrosis factor receptor type I (TNF-R1)
	Target type	Clinical trial Target
	Disease	Malignant glioma; Recurrent glioblastoma;
	Drugs	VB-111	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.